Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase[...]
Key data governance questions to ask when evaluating AI solutions for[...]
05/02/2024 | Press release | Distributed by Public on 05/02/2024 00:05
Please select the service you want to use:
Smartlinks | Tokio Marine Holdings Inc. | News | Company News | Top Company News | Buyback, Treasury Shares and Liquidity Agreements | Financial Services | Insurance | Securities Issuers | Multiline Insurance and Brokers | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Buenos Aires Stock Exchange (BCBA) | OTC Markets | Tokyo Stock Exchange (TSE) | Chi-X Japan | SBI Japannext
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact